381 related articles for article (PubMed ID: 17272756)
1. Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.
Harder C; Lau P; Meng A; Whitman SC; McPherson R
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):858-64. PubMed ID: 17272756
[TBL] [Abstract][Full Text] [Related]
2. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
[TBL] [Abstract][Full Text] [Related]
3. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
[TBL] [Abstract][Full Text] [Related]
4. Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.
Zhou H; Li Z; Silver DL; Jiang XC
Biochim Biophys Acta; 2006 Dec; 1761(12):1482-8. PubMed ID: 17055779
[TBL] [Abstract][Full Text] [Related]
5. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice.
Zhang S; Picard MH; Vasile E; Zhu Y; Raffai RL; Weisgraber KH; Krieger M
Circulation; 2005 Jun; 111(25):3457-64. PubMed ID: 15967843
[TBL] [Abstract][Full Text] [Related]
6. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells.
Covey SD; Krieger M; Wang W; Penman M; Trigatti BL
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1589-94. PubMed ID: 12829524
[TBL] [Abstract][Full Text] [Related]
7. Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver.
Gauthier A; Lau P; Zha X; Milne R; McPherson R
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2177-84. PubMed ID: 16123327
[TBL] [Abstract][Full Text] [Related]
8. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
Hong SC; Zhao SP; Wu ZH
Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
[TBL] [Abstract][Full Text] [Related]
9. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice.
Brundert M; Ewert A; Heeren J; Behrendt B; Ramakrishnan R; Greten H; Merkel M; Rinninger F
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):143-8. PubMed ID: 15528479
[TBL] [Abstract][Full Text] [Related]
10. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
[TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.
Klerkx AH; El Harchaoui K; van der Steeg WA; Boekholdt SM; Stroes ES; Kastelein JJ; Kuivenhoven JA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):706-15. PubMed ID: 16439711
[TBL] [Abstract][Full Text] [Related]
12. Effect of CETP on the plasma lipoprotein profile in four strains of transgenic mouse.
Takahashi H; Takahashi A; Maki M; Sasai H; Kamada M
Biochem Biophys Res Commun; 2001 Apr; 283(1):118-23. PubMed ID: 11322777
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.
Gautier T; Masson D; Jong MC; Pais de Barros JP; Duverneuil L; Le Guern N; Deckert V; Dumont L; Bataille A; Zak Z; Jiang XC; Havekes LM; Lagrost L
Biochem J; 2005 Jan; 385(Pt 1):189-95. PubMed ID: 15339254
[TBL] [Abstract][Full Text] [Related]
14. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein.
Marotti KR; Castle CK; Boyle TP; Lin AH; Murray RW; Melchior GW
Nature; 1993 Jul; 364(6432):73-5. PubMed ID: 8316302
[TBL] [Abstract][Full Text] [Related]
15. Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism.
Hirano K; Ikegami C; Tsujii K; Zhang Z; Matsuura F; Nakagawa-Toyama Y; Koseki M; Masuda D; Maruyama T; Shimomura I; Ueda Y; Yamashita S
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2422-7. PubMed ID: 16151015
[TBL] [Abstract][Full Text] [Related]
16. Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice.
Kitayama K; Nishizawa T; Abe K; Wakabayashi K; Oda T; Inaba T; Amemiya Y
J Pharm Pharmacol; 2006 Dec; 58(12):1629-38. PubMed ID: 17331327
[TBL] [Abstract][Full Text] [Related]
17. Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques.
Svensson PA; Englund MC; Snäckestrand MS; Hägg DA; Ohlsson BG; Stemme V; Mattsson-Hulten L; Thelle DS; Fagerberg B; Wiklund O; Carlsson LM; Carlsson B
BMC Cardiovasc Disord; 2005 Aug; 5():25. PubMed ID: 16122381
[TBL] [Abstract][Full Text] [Related]
18. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport.
Tanigawa H; Billheimer JT; Tohyama J; Zhang Y; Rothblat G; Rader DJ
Circulation; 2007 Sep; 116(11):1267-73. PubMed ID: 17709636
[TBL] [Abstract][Full Text] [Related]
19. Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor.
Masson D; Koseki M; Ishibashi M; Larson CJ; Miller SG; King BD; Tall AR
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2054-60. PubMed ID: 19815817
[TBL] [Abstract][Full Text] [Related]
20. Dual effects on HDL metabolism by cholesteryl ester transfer protein inhibition in HepG2 cells.
Huang Z; Inazu A; Kawashiri MA; Nohara A; Higashikata T; Mabuchi H
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1210-9. PubMed ID: 12604506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
